D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Jack in the Box
JACK
$309M
| $1.66M | ﹤0.01% |
47,362
+13,220
| +39% | +$900K |
|
2252
Toro Company
TTC
$9.12B
| $1.66M | ﹤0.01% |
25,500
+7,932
| +45% | +$602K |
|
|
MANT
2253
DELISTED
Mantech International Corp
MANT
| $1.65M | ﹤0.01% |
22,720
-5,318
| -19% | -$415K |
|
2254
CALL
Petrobras
PBR
$116B
| $1.65M | ﹤0.01% |
300,000
-683,900
| -70% | -$8.16M |
|
|
RYZ
2255
Ryerson Holding Corp
RYZ
$1.62B
| $1.65M | ﹤0.01% |
310,143
-26,151
| -8% | -$231K |
|
2256
CALL
Goodyear
GT
$2.12B
| $1.65M | ﹤0.01% |
283,300
-35,800
| -11% | -$391K |
|
2257
PUT
Terex
TEX
$7.88B
| $1.65M | ﹤0.01% |
114,800
-18,300
| -14% | -$414K |
|
2258
Robert Half
RHI
$4.13B
| $1.65M | ﹤0.01% |
43,648
-77,278
| -64% | -$4.18M |
|
2259
TTM Technologies
TTMI
$11.3B
| $1.65M | ﹤0.01% |
159,218
+113,483
| +248% | +$1.49M |
|
|
EXTN
2260
DELISTED
Exterran Corporation
EXTN
| $1.64M | ﹤0.01% |
341,852
-259,136
| -43% | -$1.55M |
|
2261
PUT
Bilibili
BILI
$7.55B
| $1.64M | ﹤0.01% |
+70,000
| New | +$1.69M |
|
2262
Mohawk Industries
MHK
$7.2B
| $1.64M | ﹤0.01% |
21,502
-96,450
| -82% | -$11.4M |
|
2263
PUT
Capital One
COF
$128B
| $1.63M | ﹤0.01% |
32,400
+23,600
| +268% | +$2.07M |
|
2264
PUT
Accenture
ACN
$101B
| $1.63M | ﹤0.01% |
10,000
+6,700
| +203% | +$1.29M |
|
2265
B&G Foods
BGS
$300M
| $1.63M | ﹤0.01% |
89,962
+65,823
| +273% | +$1.03M |
|
|
FRGI
2266
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.63M | ﹤0.01% |
403,818
-251,590
| -38% | -$2.2M |
|
2267
NIO
NIO
$11.7B
| $1.63M | ﹤0.01% |
585,026
-6,125,677
| -91% | -$22.8M |
|
2268
Cactus
WHD
$3.7B
| $1.62M | ﹤0.01% |
139,966
+77,003
| +122% | +$1.93M |
|
2269
PUT
Neurocrine Biosciences
NBIX
$18.2B
| $1.62M | ﹤0.01% |
+18,700
| New | +$1.83M |
|
2270
PUT
Children's Place
PLCE
$54M
| $1.62M | ﹤0.01% |
82,700
-1,800
| -2% | -$95.4K |
|
2271
Xenon Pharmaceuticals
XENE
$6.28B
| $1.62M | ﹤0.01% |
142,508
+95,631
| +204% | +$1.36M |
|
|
NP
2272
DELISTED
Neenah, Inc. Common Stock
NP
| $1.62M | ﹤0.01% |
+37,457
| New | +$2.22M |
|
|
AXON
2273
PUT
Axon Enterprise
AXON
$43.8B
| $1.61M | ﹤0.01% |
22,800
-1,800
| -7% | -$135K |
|
2274
PUT
Penumbra
PEN
$12.6B
| $1.61M | ﹤0.01% |
+10,000
| New | +$1.68M |
|
2275
CALL
Dover
DOV
$27.4B
| $1.61M | ﹤0.01% |
19,200
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.